Whole exome sequencing identified a known pathogenic mutation in the <i>SLC52A2</i> gene consistent with a diagnosis of Brown-Vialetto-Van Laere syndrome despite the absence of common symptoms including motor neuropathy, bulbar palsy, optic atrophy, and sensorineural hearing loss. Here, SLC52A2 is linked to riboflavin transporter deficiency.